Our study highlights the essential role of the TRIM59-IRF6-PGM1 axis in regulating glycolysis-mediated neuroblastoma tumor cell growth, providing potential intervention targets for novel therapeutic regimens involving neuroblastoma metabolism. This evidence concerns the gene IRF6 and neuroblastoma.